Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
about
Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infantsAntiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.Mitochondrial toxicity and HIV therapy.Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1.Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothersZidovudine use in pregnancy and congenital malformations.Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
P2860
Q33747993-0B06EBF7-FA62-4DAC-BF7F-D43A96EBCCCFQ33996797-ACCF9525-1B02-468E-B874-0B87ED489FD7Q34181048-92819466-B96A-4FDA-A9B4-541B3D04799FQ34279271-15DF058E-F9A4-4E16-8D51-C3BDCD20E3F2Q35327135-C777F8C1-EDC0-4E79-B1C2-049EDC958738Q35924264-10F4D0D2-FB0E-4F18-A23B-4C9D3AC158C0Q36077016-FD6D0C80-62DB-4076-8594-2C320D3550E0Q36379162-0B7A04BA-0F14-40FC-B39C-3758426870DAQ36438846-F10A16C1-1F83-421D-B8CB-B6AEFEAE9217
P2860
Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@ast
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@en
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@nl
type
label
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@ast
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@en
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@nl
prefLabel
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@ast
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@en
Drug safety during pregnancy a ...... in pediatric HIV surveillance.
@nl
P2093
P1476
Drug safety during pregnancy a ...... in pediatric HIV surveillance
@en
P2093
M L Lindegren
Perinatal Safety Review Working Group
State and Local Health Department HIV/AIDS Surveillance Programs
P304
P407
P577
2000-11-01T00:00:00Z